BioMarin Reports One Oral, Seven Poster Presentations at ACMGG Annual Meeting

By: via Benzinga
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced the results of a post-hoc sub-analysis of the PKU-016 or ASCEND study, the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.